Clinical profile and management of patients with chronic ischemic heart disease according to age in the population daily attended by cardiologists in Spain. The ELDERCIC study

European Journal of Internal Medicine

Volumn 21, Issue 3, 2010, Pages 180-184

  Barrios, Vivencio ^a   Escobar, Carlos ^b   Murga, Nekane ^c   Quijano, Juan Jose ^d  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d Recordati Pharmaceuticals Spain   (Spain)

Author keywords

Age; Chronic; Ischemic heart disease; Older people; Treatment control

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOLOGIST; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELDERLY CARE; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; GLYCEMIC CONTROL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; SMOKING; SPAIN; STRESS ECHOCARDIOGRAPHY;

AGE DISTRIBUTION; AGED; BLOOD PRESSURE; CARDIOLOGY; CHOLESTEROL, LDL; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROFESSIONAL PRACTICE; RISK FACTORS; SMOKING; SPAIN;

EID: 77952319143     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.01.003     Document Type: Article

References (29)

1. Fox C.S., Evans J.C., Larson M.G., Kannel W.B., and Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999. The Framingham Heart study. Circulation 110 (2004) 522-527
2. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F., et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27 (2006) 1341-1381
3. Jørgensen S., Køber L., Ottesen M., Torp-Pedersen C., Videbaek J., and Kjøller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. J Cardiovasc Risk 6 (1999) 23-27
4. Doughty M., Mehta R., Bruckman D., Das S., Karavite D., Tsai T., et al. Acute myocardial infarction in the young-the University of Michigan experience. Am Heart J 143 (2002) 56-62
5. Anderson R.E., Pfeffer M.A., Thune J.J., McMurray J.J., Califf R.M., Velazquez E., et al. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Am Heart J 155 (2008) 706-711
6. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000) 1887-1892
7. Steg P.G., Lopez-Sendon J., Lopez de Sa E., Goodman S.G., Gore J.M., Anderson Jr. F.A., et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 167 (2007) 68-73
8. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187
9. Rosendorff C., Black H.R., Cannon C.P., Gersh B.J., Gore J., Izzo Jr. J.L., et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115 (2007) 2761-2788
10. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 (2008) 2388-2442
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
12. American Diabetes Association. Clinical practice recommendations 2005. Diabetes Care 28 Suppl 1 (2005) S1-S79
13. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28 (2007) 2375-2414
14. Tunstall-Pedoe H., Kuulasmaa K., Mähönen M., Tolonen H., Ruokokoski E., and Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353 (1999) 1547-1557
15. Wenger N.K., Lewis S.J., Herrington D.M., Bittner V., and Welty F.K. Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med 147 (2007) 1-9
16. White H.D., Aylward P.E., Huang Z., Dalby A.J., Weaver W.D., Barvik S., et al. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation 112 (2005) 3391-3399
17. Mason C.M. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model. J Am Acad Nurse Pract 21 (2009) 47-53
18. Levine B.S., and Kannel W.B. Coronary heart disease risk in people 65 years of age and older. Prog Cardiovasc Nurs 18 (2003) 135-140
19. Barrios V., Escobar C., Bertomeu V., Murga N., de Pablo C., and Calderón A. Risk factor control in the hypertensive patients with chronic ischemic heart disease attended in cardiologic outpatient clinics. The CINHTIA study. Rev Clin Esp 208 (2008) 400-404
20. Barrios V., Escobar C., Bertomeu V., Murga N., de Pablo C., and Calderón A. Sex differences in the hypertensive population with chronic ischemic heart disease. J Clin Hypertens (Greenwich). 10 (2008) 779-786
21. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., and de Boer M.J. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28 (2007) 88-136
22. Choudhury L., and Marsh J.D. Myocardial infarction in young patients. Am J Med 107 (1999) 254-261
23. Barbash G.I., White H.D., Modan M., Diaz R., Hampton J.R., Heikkila J., et al. Acute myocardial infarction in the young-the role of smoking. Eur J Heart 16 (1995) 313-316
24. Rallidis L.S., Lekakis J., Panagiotakos D., Fountoulaki K., Komporozos C., Apostolou T., et al. Long-term prognostic factors of young patients (< or = 35 years) having acute myocardial infarction: the detrimental role of continuation of smoking. Eur J Cardiovasc Prev Rehabil 15 (2008) 567-571
25. Fournier J.A., Cabezón S., Cayuela A., Ballesteros S.M., Cortacero J.A., and Díaz De La Llera L.S. Long-term prognosis of patients having acute myocardial infarction when
26. Flather M.D., Yusuf S., Kober L., Pfeffer M., Hall A., Murray G., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 355 (2000) 1575-1581
27. Kjekshus J., Apetrei E., Barrios V., Böhm M., Cleland J.G., Cornel J.H., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007) 2248-2261
28. Cortigiani L., Bigi R., Sicari R., Landi P., Bovenzi F., and Picano E. Prognostic implications of dipyridamole or dobutamine stress echocardiography for evaluation of patients > or = 65 years of age with known or suspected coronary heart disease. Am J Cardiol 99 (2007) 1491-1495
29. Driver J.A., Djoussé L., Logroscino G., Gaziano J.M., and Kurth T. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 337 (2008) a2467